Clinical Trial Update: A Study to Test if TEV-48574 is Effective in Relieving Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial of TEV-48574 in asthma was terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• TEV-48574

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Asthma | Phase 2 | Status: TERMINATED | Results posted: 2023-03-13